J&J halts US rollout of varipulse heart device
USA—Johnson & Johnson MedTech has temporarily halted the rollout of its Varipulse heart device...
Read More
Tag: Johnson & Johnson
Johnson & Johnson rebrands in South Africa to enhance healthcare innovation
SOUTH AFRICA—Johnson & Johnson has announced a significant rebranding in South Africa, uniting...
Read More
J&J invests over US$2B in new biologics manufacturing facility in North Carolina
USA—Johnson & Johnson(J&J) has announced its plan to invest of over US$2 billion to...
Read More
Johnson & Johnson seeks FDA Approval for promising multiple myeloma therapy
USA — Johnson & Johnson has filed a supplemental Biologics License Application (sBLA) with the...
Read More
FDA approves Rybrevant combo for advanced lung cancer
USA—The U.S. Food and Drug Administration (FDA) has approved RYBREVANT® (amivantamab-vmjw) in...
Read More
Johnson & Johnson receives FDA Approval for new lung cancer treatment
USA—Johnson & Johnson has received FDA approval for RYBREVANT® (amivantamab-vmjw) combined...
Read More
J&J invests US$850M in Proteologix acquisition to enhance dermatology portfolio
USA – Johnson & Johnson (J&J) has announced a definitive agreement to acquire...
Read More
PPB recalls Benylin Pediatric cough syrup due to safety concerns
KENYA—The Pharmacy and Poisons Board (PPB), Kenya’s drug regulator, has announced the recall of...
Read More
Johnson & Johnson sets sights on 20 drug launches amidst Stelara patent pressures
USA — Johnson & Johnson has set an ambitious goal, aiming to introduce a minimum of 20 new...
Read More
Johnson & Johnson MedTech invests US$400 million in cutting-edge device to address atrial fibrillation complications
USA – Johnson & Johnson MedTech has disclosed a substantial upfront investment of US$400...
Read More
LATEST DIGITAL MAGAZINE
